LifeMD, Inc. Provides Earnings Guidance for the First Quarter of 2024 and Revises Earnings Guidance for the Full Year of 2024
March 11, 2024 at 04:05 pm EDT
Share
LifeMD, Inc. provided earnings guidance for the first quarter of 2024 and revised earnings guidance for the full year of 2024. For the quarter, the company expects revenue to be between $42 million and $43 million.
For the full year, the company expects revenue to be at least $200 million reflecting performance to date in GLP-1 weight management program exceeding previous guidance, raised from previous guidance of $195 million to $205 million. As this guidance implies, the company expects revenue growth of at least 31%.
LifeMD, Inc. is a direct-to-patient telehealth company, which provides comprehensive virtual and in-home healthcare. The Company operates through two segments: Telehealth and WorkSimpli. Telehealth segment is engaged in telehealth platform, which integrates a clinician-centric electronic medical record (EMR) system, algorithms for case-load balancing and scheduling, customer relationship management functionality, asynchronous communication, secure synchronous, cloud pharmacy and more. Its technology platform, combined with its 50-state affiliated provider network, enables the management of virtual treatment offerings across various health conditions, including, dermatology, urgent and primary care, chronic care management, dermatology, chronic care management and other. Its WorkSimpli segment offers workplace and document services. This segment offers PDFSimpli an online software as a service platform that allows users to create, edit, convert, sign and share PDF documents.
LIFEMD, INC. 
